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One approach to the treatment of cancer is to direct beta-emitting 
radionuclide to the cancer site where the radiation destroys the cancer 
cells. This can be achieved by coordinating the radioisotope in a very stable 
environment and linking it to a specific biological targeting molecule, which 
interacts specifically with particular cancer cells. It is necessary to have 
extremely stable in vivo radionuclide complexes so that limited amounts of 
radiation are released to other parts of the body before the radionuclide can 
reach the cancer cells. Isotopes of radioactive Rhenium are characteristic of 
such a nuclide. Our emphasis was to obtain a Rhenium (III) metal ligand 
complex since the lower oxidation state is more kinetically inert relative to 
Rhenium (V). 
  
The method employed was to first produce the ReV-ligand 
complex, [ReVOCl(Sal2phen)], by reacting a 1:2 molar ratio of TBA[ReVIIOCl4] to 
Sal2phen.  Next, [ReVOCl(Sal2phen)] was reacted with three equivalents of 
triphenylphosphine to determine whether a mono-substituted ReV complex or a 
di-substituted ReIII complex was formed. After purifying the product by solvent 
extraction, the coordinated complex was reacted with ammonium 
hexaflurophoshate, NH4PF6, to induce crystallization of the target compound, 
[ReIII(PPh3)2(Sal2phen)][PF6]. Preliminary 1H NMR, and FT-IT spectra suggest 
formation of trans-[ReIII(PPh3)2(sal2phen)]PF6. The Re=O stretch at 951.36 cm-1 
observed for [ReOCl(sal2phen)] in the IR spectrum is missing  from our 
product, implying the Re (III) product has been formed. 
 
